Works matching Hepatitis treatment

Results: 5000
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan.

    Published in:
    Hepatology Research, 2010, v. 40, n. 1, p. 8, doi. 10.1111/j.1872-034X.2009.00634.x
    By:
    • Kumada, Hiromitsu;
    • Okanoue, Takeshi;
    • Onji, Morikazu;
    • Moriwaki, Hisataka;
    • Izumi, Namiki;
    • Tanaka, Eiji;
    • Chayama, Kazuaki;
    • Sakisaka, Shotaro;
    • Takehara, Tetsuo;
    • Oketani, Makoto;
    • Suzuki, Fumitaka;
    • Toyota, Joji;
    • Nomura, Hideyuki;
    • Yoshioka, Kentaro;
    • Seike, Masataka;
    • Yotsuyanagi, Hiroshi;
    • Ueno, Yoshiyuki
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.

    Published in:
    PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0194704
    By:
    • Mashiba, Toshie;
    • Joko, Kouji;
    • Kurosaki, Masayuki;
    • Ochi, Hironori;
    • Osaki, Yukio;
    • Kojima, Yuji;
    • Nakata, Ryo;
    • Goto, Tohru;
    • Takehiro, Akahane;
    • Kimura, Hiroyuki;
    • Mitsuda, Akeri;
    • Kawanami, Chiharu;
    • Uchida, Yasushi;
    • Ogawa, Chikara;
    • Kusakabe, Atsunori;
    • Narita, Ryuichi;
    • Ide, Yasushi;
    • Abe, Takehiko;
    • Tsuji, Keiji;
    • Kitamura, Tadashi
    Publication type:
    Article
    40
    41
    42

    Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: Project of the Kyushu University Liver Disease Study Group

    Published in:
    Journal of Gastroenterology & Hepatology, 2008, v. 23, n. 7pt1, p. 1094, doi. 10.1111/j.1440-1746.2008.05319.x
    By:
    • Furusyo, Norihiro;
    • Kajiwara, Eiji;
    • Takahashi, Kazuhiro;
    • Nomura, Hideyuki;
    • Tanabe, Yuichi;
    • Masumoto, Akihide;
    • Maruyama, Toshihiro;
    • Nakamuta, Makoto;
    • Enjoji, Munehika;
    • Azuma, Koichi;
    • Shimono, Junya;
    • Sakai, Hironori;
    • Shimoda, Shinji;
    • Hayashi, Jun
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50

    The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus‐infected people who inject drugs in England.

    Published in:
    Addiction, 2019, v. 114, n. 6, p. 1113, doi. 10.1111/add.14569
    By:
    • Harrison, Graham I.;
    • Murray, Karen;
    • Gore, Roxanne;
    • Lee, Penelope;
    • Sreedharan, Aravamuthan;
    • Richardson, Paul;
    • Hughes, Amanda J.;
    • Wiselka, Martin;
    • Gelson, Will;
    • Unitt, Esther;
    • Ratcliff, Karen;
    • Orton, Annette;
    • Trinder, Kerry;
    • Simpson, Charlotte;
    • Ryder, Stephen D.;
    • Oelbaum, Sandra;
    • Foster, Graham R.;
    • Christian, Archie;
    • Smith, Stuart;
    • Thomson, Brian J.
    Publication type:
    Article